REQUEST A DEMO
Total
USD $0.00
Search more companies

Hannclem Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Hannclem Pharma S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Hannclem Pharma S.A.S. is an enterprise based in Colombia. Its main office is in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 24, 2015. 38 (2023) employees currently work for Hannclem Pharma S.A.S.. From the latest financial highlights, Hannclem Pharma S.A.S. reported a net sales revenue increase of 162.1% in 2022. Over the same period, its total assets grew by 228.98%. The net profit margin of Hannclem Pharma S.A.S. increased by 0.82% in 2022.

Headquarters
Cr 51 Cl 76 199 Of 202
Barranquilla; Atlantico;

Contact Details: Purchase the Hannclem Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Hannclem Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Hannclem Pharma S.A.S. report to view the information.
Incorporation Date:
September 24, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Hannclem Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
162.1%
Total operating revenue
162.1%
Net Profit (Loss) for the Period
204.72%
Total assets
228.98%
Total equity
628.28%
Net Profit Margin
0.82%
Return on Equity (ROE)
-43.72%
Quick Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?